FDA to Review Treatment Injected into Metastatic Melanoma Tumors

cancercommons.org - Amgen | Feb 11, 2015

The gist: A treatment for metastatic melanoma called talimogene laherparepvec (T-VEC) will soon be reviewed by the FDA for treating patients with …

View on cancercommons.org